Psychotropic medication use and risk of adverse cardiovascular events in women with suspected coronary artery disease: outcomes from the Women’s Ischemia Syndrome Evaluation (WISE) study
Authors:
Abstract
Objective: This study investigated the relation between psychotropic medication use and adverse cardiovascular (CV) events in women with symptoms of myocardial ischaemia undergoing coronary angiography. Method: Women enrolled in the Women’s Ischemia Syndrome Evaluation (WISE) were classified into one of four groups according to their reported antidepressant and anxiolytic medication usage at study intake: (1) no medication (n = 352); (2) anxiolytics only (n = 67); (3) antidepressants only (n = 58); and (4) combined antidepressant and anxiolytics (n = 39). Participants were followed prospectively for the development of adverse CV events (for example, hospitalisations for non-fatal myocardial infarction, stroke, congestive heart failure and unstable angina) or all-cause mortality over a median of 5.9 years. Results: Use of antidepressant medication was associated with subsequent CV events (HR 2.16, 95% CI 1.21 to 3.93) and death (HR 2.15, 95% CI 1.16 to 3.98) but baseline anxiolytic use alone did not predict subsequent CV events and death. In a final regression model that included demographics, depression and anxiety symptoms, and risk factors for cardiovascular disease, women in the combined medication group (that is, antidepressants and anxiolytics) had higher risk for CV events (HR 3.98, CI 1.74 to 9.10, p = 0.001 and all-cause mortality (HR 4.70, CI 1.7 to 2.97, p = 0.003) compared to those using neither medication. Kaplan-Meier survival curves indicated that there was a significant difference in mortality among the four medication groups (p = 0.001). Conclusions: These data suggest that factors related to psychotropic medication such as depression refractory to treatment, or medication use itself, are associated with adverse CV events in women with suspected myocardial ischaemia.Keywords
This publication has 30 references indexed in Scilit:
- Do Depression or Antidepressants Increase Cardiovascular Mortality?: The Absence of Proof Might Be More Important Than the Proof of AbsenceJACC, 2009
- Cyclic antidepressants and the risk of sudden cardiac deathClinical Pharmacology & Therapeutics, 2004
- Prescription psychotropic medication use among the U.S. adult population: results from the third National Health and Nutrition Examination Survey, 1988–1994Journal of Clinical Epidemiology, 2004
- Depression as a risk factor for mortality after coronary artery bypass surgeryThe Lancet, 2003
- Effects of Treating Depression and Low Perceived Social Support on Clinical Events After Myocardial InfarctionJAMA, 2003
- Sertraline Treatment of Major Depression in Patients With Acute MI or Unstable AnginaJAMA, 2002
- Short-term effects of intravenous benzodiazepines on autonomic neurocardiac regulation in humans: A comparison between midazolam, diazepam, and lorazepamCritical Care Medicine, 2002
- Selective Serotonin Reuptake Inhibitors and Myocardial InfarctionCirculation, 2001
- Panic disorder in patients with chest pain and angiographically normal coronary arteriesThe American Journal of Cardiology, 1989
- DRUGS AND SUDDEN CARDIAC DEATHAnnals of the New York Academy of Sciences, 1982